M Tracie Shea1,2, Robert L Stout3, Madhavi K Reddy4, Elizabeth Sevin1, Candice Presseau5,6, Jennifer Lambert1,2, Amy Cameron1,2. 1. VA Providence Healthcare System, Providence, Rhode Island, USA. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island, USA. 3. Pacific Institute for Research and Evaluation, Pawtucket, Rhode Island, USA. 4. Walter Reed Army Institute of Research, Silver Spring, Maryland, USA. 5. VA Connecticut Health Care System, West Haven, Connecticut, USA. 6. Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Abstract
BACKGROUND: Problems with anger and aggression affect many veterans who have deployed to a warzone, resulting in serious impairment in multiple aspects of functioning. Controlled studies are needed to improve treatment options for these veterans. This randomized controlled trial compared an individually delivered cognitive behavioral therapy adapted from Novaco's Anger Control Therapy to a manualized supportive therapy to control for common therapeutic factors. METHODS: Ninety-two post-911 veterans deployed during Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), or Operation New Dawn (OND) with moderate to severe anger problems were randomized to receive the cognitive behavioral intervention (CBI) or the supportive intervention (SI). Anger, aggression, multiple areas of functioning and quality of life were assessed at multiple time points inclu\ding 3- and 6-month follow-up. RESULTS: Hierarchical linear modeling (HLM) analyses showed significant treatment effects favoring CBI for anger severity, social and interpersonal functioning, and quality of life. The presence of a PTSD diagnosis did not affect outcomes. CONCLUSIONS: CBI is an effective treatment for OEF/OIF/OND veterans with anger problems following deployment, regardless of PTSD diagnosis.
BACKGROUND: Problems with anger and aggression affect many veterans who have deployed to a warzone, resulting in serious impairment in multiple aspects of functioning. Controlled studies are needed to improve treatment options for these veterans. This randomized controlled trial compared an individually delivered cognitive behavioral therapy adapted from Novaco's Anger Control Therapy to a manualized supportive therapy to control for common therapeutic factors. METHODS: Ninety-two post-911 veterans deployed during Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), or Operation New Dawn (OND) with moderate to severe anger problems were randomized to receive the cognitive behavioral intervention (CBI) or the supportive intervention (SI). Anger, aggression, multiple areas of functioning and quality of life were assessed at multiple time points inclu\ding 3- and 6-month follow-up. RESULTS: Hierarchical linear modeling (HLM) analyses showed significant treatment effects favoring CBI for anger severity, social and interpersonal functioning, and quality of life. The presence of a PTSD diagnosis did not affect outcomes. CONCLUSIONS: CBI is an effective treatment for OEF/OIF/OND veterans with anger problems following deployment, regardless of PTSD diagnosis.
Authors: Paula P Schnurr; Matthew J Friedman; Charles C Engel; Edna B Foa; M Tracie Shea; Bruce K Chow; Patricia A Resick; Veronica Thurston; Susan M Orsillo; Rodney Haug; Carole Turner; Nancy Bernardy Journal: JAMA Date: 2007-02-28 Impact factor: 56.272
Authors: Leslie A Morland; Carolyn J Greene; Craig S Rosen; David Foy; Patrick Reilly; Jay Shore; Qimei He; B Christopher Frueh Journal: J Clin Psychiatry Date: 2010-01-26 Impact factor: 4.384
Authors: Shannon R Miles; Kirsten H Dillon; Vanessa M Jacoby; Willie J Hale; Katherine A Dondanville; Jennifer Schuster Wachen; Jeffrey S Yarvis; Alan L Peterson; Jim Mintz; Brett T Litz; Stacey Young-McCaughan; Patricia A Resick Journal: J Clin Psychol Date: 2019-11-16
Authors: Bradley E Belsher; Erin Beech; Daniel Evatt; Derek J Smolenski; M Tracie Shea; Jean Lin Otto; Craig S Rosen; Paula P Schnurr Journal: Cochrane Database Syst Rev Date: 2019-11-18
Authors: M Tracie Shea; Robert L Stout; Madhavi K Reddy; Elizabeth Sevin; Candice Presseau; Jennifer Lambert; Amy Cameron Journal: Depress Anxiety Date: 2021-12-08 Impact factor: 8.128